ArticleTheranostics2022

Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.

Andrei Maiseyeu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.